What if my test is inconclusive?
BRCA 1/2 genetic testing does not always give a clear yes/no answer. Many different mutations have been identified in BRCA1/2 genes but not all have been linked with an increased risk of cancer. These mutations are known as ‘variants of uncertain significance’ (VUS).
Identifying a VUS means that an abnormality has been found in your BRCA1/2 gene test, but that based on available information, the specific mutation found has not been linked to an increased risk of developing cancer.
As we learn more about variants of uncertain significance some might be re-classified as being ‘clinically significant’ and hence associated with an increased risk of developing cancer. This information is constantly being updated according to NICE clinical guideline CG164 1.5.10.
If your test results show a VUS then NICE clinical guideline CG164 1.5.9 advises that you can request a review in the future to see whether your VUS has been classified as a BRCA1/2 gene mutation.
A positive test result
If you have tested positive for a BRCA1/2 mutation you will also have a higher risk of developing some other cancers. This risk is shown in the table below.
These are NHS England guidelines. We are currently developing tailored information for patients in Scotland, Wales and Northern Irleand. If you have any questions in the meantime please contact Ross@ovarian.org.uk